Learn more

HANKOOK PHARM CO INC

Overview
  • Total Patents
    69
  • GoodIP Patent Rank
    175,424
  • Filing trend
    ⇩ 75.0%
About

HANKOOK PHARM CO INC has a total of 69 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 1993. It filed its patents most often in Republic of Korea, China and United States. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are HLSCIENCE CO LTD, JEONNAM BIOINDUSTRY FOUNDATION and SHAKLEE CORP.

Patent filings in countries

World map showing HANKOOK PHARM CO INCs patent filings in countries

Patent filings per year

Chart showing HANKOOK PHARM CO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Jin Pyo 32
#2 Yoo Jae Kuk 28
#3 Yoo Jae Guk 23
#4 Hong Nam Du 17
#5 Park Byeong Wook 11
#6 Lee Chan Bok 10
#7 Cho Su Muk 10
#8 Bae Ki Hwan 9
#9 Min Dong Il 8
#10 Na Min Gyun 7

Latest patents

Publication Filing date Title
KR20190136679A Composition for enhancing immune system containing mixture of extract of Phellinuse Linteus and extract of silkworm as an active ingredient
KR20190007167A Granule formulation comprising aster koraiensis extract
KR20190007163A Liquid formulation comprising aster koraiensis extract
KR20190007165A Pill formulation comprising aster koraiensis extract
KR101865292B1 Culture medium composition comprising mushroom extract for culturing phellinus linteus and culture method of phellinus linteus using thereof
KR20180051077A Formulation comprising Aster koraiensis extract
KR20170011499A Culture method for increasing the amount of basidiomycete mycelium and polysaccharide
KR20110119606A Pharmaceurtical compositions for the prevention or treatment of cancer containing the mixed extract of phellinus linteus mycelium and cultured panax ginseng cameyer as an active ingredient
KR20120078327A Moisturizing and/or whitening cosmetic composition comprising polysaccharide extracted from lentinus edodes mycelium culture product
KR20120015874A Pharmaceutical compositions for prevention or treatment of cerebrovascular disease, or for improving impairments, containing the extracts of ilex latifolia as an active ingredient
KR20110134641A Pharmaseutical compositions for prevention or treatment of cerebrovascular disease, or for improving impairments, containing the extracts of curcuma longae radix, phellinus linteus and scutellariae radix as an active ingredient
KR20110085151A Megastigmane derivatives isolated from ilex paraguariensis, preparation method thereof and anti-wrinkle composition containing the same as an active ingredient
KR20110058041A Health functional foods compositions for the prevention and amelioration of cancer containing the mixed extract of phellinus linteus mycelium and cultured panax ginseng cameyer as an active ingredient
KR20110043194A Anti-wrinkle composition containing the extract or fraction of ilex paraguariensis as an active ingregient
KR20110043195A Anti-wrinkle composition containing caffeoylquinic acid derivatives, pharmaceutically acceptable salts thereof as an active ingredient
KR20100079303A Anticancer health foods including phellinus linteus and vegetable worms
KR20100079279A Anticancer health foods including fermented ginseng with medicinal mushroom
KR20100079269A Anticancer health foods including fermented ginseng with mushroom
US2010291154A1 Composition for inhibition of transplant rejection containing the cordyceps mycellia extract as an active ingredient
KR20100112598A Composition for inhibition of trasplant rejection containing the phellinus linteus mycellia extract as an active ingredient